241 related articles for article (PubMed ID: 7940683)
1. Impact of de novo membranous glomerulonephritis on the clinical course after kidney transplantation.
Schwarz A; Krause PH; Offermann G; Keller F
Transplantation; 1994 Sep; 58(6):650-4. PubMed ID: 7940683
[TBL] [Abstract][Full Text] [Related]
2. Recurrence of de novo membranous glomerulonephritis on renal grafts.
Heidet L; Gagnadoux ME; Beziau A; Niaudet P; Broyer M; Habib R
Clin Nephrol; 1994 May; 41(5):314-8. PubMed ID: 8050213
[TBL] [Abstract][Full Text] [Related]
3. Membranous glomerulonephritis (MGN) in transplanted kidneys: morphologic investigation on 256 renal allografts.
Monga G; Mazzucco G; Basolo B; Quaranta S; Motta M; Segoloni G; Amoroso A
Mod Pathol; 1993 May; 6(3):249-58. PubMed ID: 8346172
[TBL] [Abstract][Full Text] [Related]
4. Recurent and de novo membranous glomerulopathy after kidney transplantation.
Aline-Fardin A; Rifle G; Martin L; Justrabo E; Bour JB; D'Athis P; Tanter Y; Mousson C
Transplant Proc; 2009 Mar; 41(2):669-71. PubMed ID: 19328952
[TBL] [Abstract][Full Text] [Related]
5. Proteinuria following transplantation. Correlation with histopathology and outcome.
First MR; Vaidya PN; Maryniak RK; Weiss MA; Munda R; Fidler JP; Penn I; Alexander JW
Transplantation; 1984 Dec; 38(6):607-12. PubMed ID: 6390821
[TBL] [Abstract][Full Text] [Related]
6. [Cooperative study of de novo extramembranous glomerulonephritis in renal allografts in humans: report of 19 new cases in 1550 renal transplant patients of the transplantation group of the Ile de France].
Charpentier B; Lévy M
Nephrologie; 1982; 3(4):158-66. PubMed ID: 6759963
[TBL] [Abstract][Full Text] [Related]
7. [A case of membranous glomerulonephritis in renal allograft].
Kanno T; Ito M; Kawase N; Taki Y; Yoshida H; Okuno H; Ogawa O
Hinyokika Kiyo; 2002 Jun; 48(6):379-82. PubMed ID: 12166242
[TBL] [Abstract][Full Text] [Related]
8. [Efficiency of rituximab treatment for recurrence of membranous glomerulopathy after renal transplantation].
Wéclawiak H; Ribes D; Modesto A; Kamar N; Durand D; Rostaing L
Nephrol Ther; 2007 Apr; 3(2):65-8. PubMed ID: 17452303
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
Thervet E; Pfeffer P; Scolari MP; Toselli L; Pallardó LM; Chadban S; Pilmore H; Connolly J; Buchler M; Schena FP; Carreño CA; Dandavino R; Cole E
Transplantation; 2003 Sep; 76(6):903-8. PubMed ID: 14508352
[TBL] [Abstract][Full Text] [Related]
10. De novo membranous glomerulonephritis in renal allografts in children.
Antignac C; Hinglais N; Gubler MC; Gagnadoux MF; Broyer M; Habib R
Clin Nephrol; 1988 Jul; 30(1):1-7. PubMed ID: 3061691
[TBL] [Abstract][Full Text] [Related]
11. Untreated rejection in 6-month protocol biopsies is not associated with fibrosis in serial biopsies or with loss of graft function.
Scholten EM; Rowshani AT; Cremers S; Bemelman FJ; Eikmans M; van Kan E; Mallat MJ; Florquin S; Surachno J; ten Berge IJ; Bajema IM; de Fijter JW
J Am Soc Nephrol; 2006 Sep; 17(9):2622-32. PubMed ID: 16899517
[TBL] [Abstract][Full Text] [Related]
12. Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients.
Morales JM; Pascual-Capdevila J; Campistol JM; Fernandez-Zatarain G; Muñoz MA; Andres A; Praga M; Martinez MA; Usera G; Fuertes A; Oppenheimer F; Artal P; Darnell A; Rodicio JL
Transplantation; 1997 Jun; 63(11):1634-9. PubMed ID: 9197359
[TBL] [Abstract][Full Text] [Related]
13. Recurrence of membranous nephropathy after renal transplantation. Incidence and risk factors in 1614 patients.
Couchoud C; Pouteil-Noble C; Colon S; Touraine JL
Transplantation; 1995 May; 59(9):1275-9. PubMed ID: 7762061
[TBL] [Abstract][Full Text] [Related]
14. Nephrotic syndrome after stem cell transplantation.
Stevenson WS; Nankivell BJ; Hertzberg MS
Clin Transplant; 2005 Feb; 19(1):141-4. PubMed ID: 15659148
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors associated with poor graft outcomes in renal recipients with post-transplant glomerulonephritis.
Requião-Moura LR; Moscoso-Solorzano GT; Franco MF; Ozaki KS; Pacheco-Silva A; Kirsztajn GM; Câmara NO
Clin Transplant; 2007; 21(3):363-70. PubMed ID: 17488386
[TBL] [Abstract][Full Text] [Related]
16. De novo membranous glomerulonephropathy in renal allografts: a report of ten cases and review of the literature.
Truong L; Gelfand J; D'Agati V; Tomaszewski J; Appel G; Hardy M; Pirani CL
Am J Kidney Dis; 1989 Aug; 14(2):131-44. PubMed ID: 2667346
[TBL] [Abstract][Full Text] [Related]
17. Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era.
Stone JH; Millward CL; Olson JL; Amend WJ; Criswell LA
Arthritis Rheum; 1998 Apr; 41(4):678-86. PubMed ID: 9550477
[TBL] [Abstract][Full Text] [Related]
18. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
Dumoulin A; Hill GS; Montseny JJ; Meyrier A
Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
[TBL] [Abstract][Full Text] [Related]
19. A primer on recurrent and de novo glomerulonephritis in renal allografts.
Ivanyi B
Nat Clin Pract Nephrol; 2008 Aug; 4(8):446-57. PubMed ID: 18560395
[TBL] [Abstract][Full Text] [Related]
20. De novo membranous nephropathy (MN) in kidney allografts. A peculiar form of alloimmune disease?
Ponticelli C; Glassock RJ
Transpl Int; 2012 Dec; 25(12):1205-10. PubMed ID: 22909324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
